Cellectis (CLLS)
(Delayed Data from NSDQ)
$2.37 USD
-0.01 (-0.42%)
Updated Aug 28, 2024 03:57 PM ET
After-Market: $2.38 +0.01 (0.42%) 7:16 PM ET
3-Hold of 5 3
B Value B Growth D Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/4/24 |
---|---|
Current Quarter | -0.20 |
EPS Last Quarter | -0.28 |
Last EPS Surprise | 15.15% |
ABR | 1.33 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.54 |
Next Year | -0.51 |
EPS (TTM) | -1.38 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 5.00M | 1.50M | 19.00M | 60.00M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 5.00M | 1.50M | 19.00M | 60.00M |
Low Estimate | 5.00M | 1.50M | 19.00M | 60.00M |
Year ago Sales | 1.64M | 1.99M | 9.19M | 19.00M |
Year over Year Growth Est. | 204.88% | -24.62% | 106.66% | 215.79% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.20 | -0.09 | -0.54 | -0.51 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | -0.20 | -0.09 | -0.54 | -0.51 |
Low Estimate | -0.20 | -0.09 | -0.54 | -0.51 |
Year ago EPS | -0.31 | -0.64 | -2.05 | -0.54 |
Year over Year Growth Est. | 35.48% | 85.94% | 73.66% | 5.56% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.20 | -0.09 | -0.54 | -0.51 |
7 Days Ago | -0.20 | -0.09 | -0.54 | -0.51 |
30 Days Ago | -0.20 | -0.09 | -0.54 | -0.51 |
60 Days Ago | -0.20 | -0.09 | -0.54 | -0.51 |
90 Days Ago | NA | NA | -1.06 | -0.89 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.20 | -0.09 | -0.54 | -0.51 |
Zacks Consensus Estimate | -0.20 | -0.09 | -0.54 | -0.51 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.28 | -0.15 | -0.64 | -0.31 | NA |
Estimate | -0.33 | NA | NA | -0.36 | NA |
Difference | 0.05 | NA | NA | 0.05 | 0.05 |
Surprise | 15.15% | NA | NA | 13.89% | 14.52% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more